Status:
COMPLETED
Treating Tinnitus Using Eutectic Mixture of Local Anesthetics (EMLA) 5% Cream
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Tinnitus
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The investigators like to learn whether EMLA cream 5% helps tinnitus patients. so far it is known that lidocaine I.V do helps tinnitus but until now it is not clear if topical anaesthetics (e.g EMLA c...
Detailed Description
The purpose of the study is to investigate whether EMLA 5% cream decreases tinnitus by comparing pretrial questionnaires to post trial questionnaires. first we are going to invite tinnitus patients f...
Eligibility Criteria
Inclusion
- mature (above 18 years old) patients that suffer tinnitus (unilateral/bilateral) with sensorineural hearing loss
Exclusion
- patients that are treated for tinnitus( psychological treatment, hearing aid)
- drugs that affect the CNS
- sensitivity to amide anaesthetic
- hepatic failure
- usage of antiarrhythmic drugs
- severe depression any patients that develops during the trial local/ systemic symptoms such as rash, pain, itching, fever, nervousness,palpitations will be omitted from the study
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT02266160
Start Date
November 1 2014
End Date
December 1 2015
Last Update
February 28 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.